Attached files
file | filename |
---|---|
10-Q - FORM 10-Q - Pharmacity Corp | c08827e10vq.htm |
EX-31.2 - EXHIBIT 31.2 - Pharmacity Corp | c08827exv31w2.htm |
EX-32.1 - EXHIBIT 32.1 - Pharmacity Corp | c08827exv32w1.htm |
EX-32.2 - EXHIBIT 32.2 - Pharmacity Corp | c08827exv32w2.htm |
Exhibit 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
PURSUANT TO SECTION 302
CHIEF EXECUTIVE OFFICER CERTIFICATION
PURSUANT TO SECTION 302
I, Randy Lubinsky, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Welltek Incorporated (the Registrant); |
|
2. | Based on my knowledge, this Quarterly Report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this Quarterly Report. |
|
3. | Based on my knowledge, the financial statements, and other financial information included in
this Quarterly Report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Registrant as of, and for, the period presented in this Quarterly
Report; |
|
4. | The Registrants other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the Registrant and have: |
a) | designed such disclosure controls and procedures or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information relating to
the Registrant, including its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this Quarterly Report is being prepared; |
||
b) | designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles; |
||
c) | evaluated the effectiveness of the Registrants disclosure controls and procedures
presented in this Quarterly Report are conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by this report based on such
evaluation; and |
||
d) | disclosed in this Quarterly Report any change in the Registrants internal control over
financial reporting that occurred during the Registrants most recent fiscal quarter (the
Registrants Third Fiscal Quarter in the case of this Quarterly Report) that has materially
affected, or is reasonably likely to materially affect, the Registrants internal control over
financial reporting; |
5. | The Registrants other certifying officer and I have disclosed, based on our most recent
evaluation of internal control, to the Registrants auditors and the audit committee of
Registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation or
internal control over financial reporting which are reasonably likely to adversely effect the
Registrants ability to record, process, summarize and report financial information; and |
||
b) | any fraud, whether or not material, that involves management or other employees who have a
significant role in the Registrants internal control; and |
Date: November 19, 2010
|
/s/ Randy Lubinsky
|
|||
Chief Executive Officer | ||||
(Principal Executive Officer) |